Profil
Christopher R.
Heery worked as Head-Clinical Trials at the National Cancer Institute from 2013 to 2016.
Served as Chief Medical Officer at Bavarian Nordic A from 2016 to 2019.
Served as Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
Served as Chief Medical Officer at Arcellx, Inc. from 2021 to 2026.
Completed undergraduate studies at Duke University.
Earned a doctorate from Brody School of Medicine in 2006.
Anciens postes connus de Christopher Heery
| Sociétés | Poste | Fin |
|---|---|---|
| ARCELLX, INC. | Directeur Technique/Scientifique/R&D | 28/04/2026 |
| PRECISION BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 23/04/2021 |
| BAVARIAN NORDIC A/S | Directeur Technique/Scientifique/R&D | 01/04/2019 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | 01/09/2016 |
Formation de Christopher Heery
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Brody School of Medicine
Brody School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcellx, Inc.
Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
















